Cargando…

Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State

SIMPLE SUMMARY: Alterations of the immune system that consist of induced inflammation and reduction in blood lymphocytes are a major factor contributing to cancer progression in patients with pancreatic carcinoma (PC). Identification of the percentage of lymphocytes in the Total number of White Bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aquilani, Roberto, Brugnatelli, Silvia, Maestri, Roberto, Boschi, Federica, Filippi, Beatrice, Perrone, Lorenzo, Barbieri, Annalisa, Buonocore, Daniela, Dossena, Maurizia, Verri, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395458/
https://www.ncbi.nlm.nih.gov/pubmed/34449579
http://dx.doi.org/10.3390/curroncol28050285
_version_ 1783744177191780352
author Aquilani, Roberto
Brugnatelli, Silvia
Maestri, Roberto
Boschi, Federica
Filippi, Beatrice
Perrone, Lorenzo
Barbieri, Annalisa
Buonocore, Daniela
Dossena, Maurizia
Verri, Manuela
author_facet Aquilani, Roberto
Brugnatelli, Silvia
Maestri, Roberto
Boschi, Federica
Filippi, Beatrice
Perrone, Lorenzo
Barbieri, Annalisa
Buonocore, Daniela
Dossena, Maurizia
Verri, Manuela
author_sort Aquilani, Roberto
collection PubMed
description SIMPLE SUMMARY: Alterations of the immune system that consist of induced inflammation and reduction in blood lymphocytes are a major factor contributing to cancer progression in patients with pancreatic carcinoma (PC). Identification of the percentage of lymphocytes in the Total number of White Blood Cells (L% TWBC) that could be associated with chemotolerance and survival time may be important for predicting treatment efficacy. The aim of this retrospective study was to highlight the best value of L% for predicting chemotolerance (n° of cycles tolerated) and survival beyond 12 months from diagnosis. The study found that L ≥ 29.7% TWBC compared to L < 29.7% predicted chemotolerance (p < 0.0001) and survival at every time point of follow-up: 6 (p = 0.04), 12 (p = 0.0003) and 18 months (p = 0.004) after diagnosis. Simple, rapid, routine laboratory data can be useful to predict treatment tolerance and efficacy in PC patients. ABSTRACT: Pancreatic Carcinoma (PC) cells have the ability to induce patient immunosuppression and to escape immunosurveillance. Low circulating lymphocytes are associated with an advanced stage of PC and reduced survival. Blood lymphocytes expressed as a percentage of Total White Blood Cells (L% TWBC) could predict chemotolerance (n° of tolerated cycles), survival time and Body Weight (BW) more effectively than lymphocytes expressed as an absolute value (L(AB) > 1500 n°/mm(3)) or lymphocytes >22%, which is the lowest limit of normal values in our laboratory. Forty-one patients with advanced PC, treated with chemotherapy, were selected for this observational retrospective study. Patients were evaluated at baseline (pre-chemotherapy), and at 6, 12 and 18 months, respectively, after diagnosis of PC. The study found L ≥ 29.7% to be a better predictor of survival (COX model, using age, sex, BW, serum creatinine, bilirubin and lymphocytes as covariates), chemotolerance (r = +0.50, p = 0.001) and BW (r = +0.35, p = 0.027) than L(AB) > 1500 or L > 22%. BW did not significantly correlate with chemotolerance or survival. The preliminary results of this study suggest that L ≥ 29.7% is more effective than L(AB) > 1500 or L > 22% at predicting chemotolerance, survival time and nutritional status. A possible impact of nutritional status on chemotherapy and survival seems to be lymphocyte-mediated given the association between BW and L%. This study may serve as the basis for future research to explore whether nutritional interventions can improve lymphopenia, and if so, how this may be possible.
format Online
Article
Text
id pubmed-8395458
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83954582021-08-28 Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State Aquilani, Roberto Brugnatelli, Silvia Maestri, Roberto Boschi, Federica Filippi, Beatrice Perrone, Lorenzo Barbieri, Annalisa Buonocore, Daniela Dossena, Maurizia Verri, Manuela Curr Oncol Article SIMPLE SUMMARY: Alterations of the immune system that consist of induced inflammation and reduction in blood lymphocytes are a major factor contributing to cancer progression in patients with pancreatic carcinoma (PC). Identification of the percentage of lymphocytes in the Total number of White Blood Cells (L% TWBC) that could be associated with chemotolerance and survival time may be important for predicting treatment efficacy. The aim of this retrospective study was to highlight the best value of L% for predicting chemotolerance (n° of cycles tolerated) and survival beyond 12 months from diagnosis. The study found that L ≥ 29.7% TWBC compared to L < 29.7% predicted chemotolerance (p < 0.0001) and survival at every time point of follow-up: 6 (p = 0.04), 12 (p = 0.0003) and 18 months (p = 0.004) after diagnosis. Simple, rapid, routine laboratory data can be useful to predict treatment tolerance and efficacy in PC patients. ABSTRACT: Pancreatic Carcinoma (PC) cells have the ability to induce patient immunosuppression and to escape immunosurveillance. Low circulating lymphocytes are associated with an advanced stage of PC and reduced survival. Blood lymphocytes expressed as a percentage of Total White Blood Cells (L% TWBC) could predict chemotolerance (n° of tolerated cycles), survival time and Body Weight (BW) more effectively than lymphocytes expressed as an absolute value (L(AB) > 1500 n°/mm(3)) or lymphocytes >22%, which is the lowest limit of normal values in our laboratory. Forty-one patients with advanced PC, treated with chemotherapy, were selected for this observational retrospective study. Patients were evaluated at baseline (pre-chemotherapy), and at 6, 12 and 18 months, respectively, after diagnosis of PC. The study found L ≥ 29.7% to be a better predictor of survival (COX model, using age, sex, BW, serum creatinine, bilirubin and lymphocytes as covariates), chemotolerance (r = +0.50, p = 0.001) and BW (r = +0.35, p = 0.027) than L(AB) > 1500 or L > 22%. BW did not significantly correlate with chemotolerance or survival. The preliminary results of this study suggest that L ≥ 29.7% is more effective than L(AB) > 1500 or L > 22% at predicting chemotolerance, survival time and nutritional status. A possible impact of nutritional status on chemotherapy and survival seems to be lymphocyte-mediated given the association between BW and L%. This study may serve as the basis for future research to explore whether nutritional interventions can improve lymphopenia, and if so, how this may be possible. MDPI 2021-08-26 /pmc/articles/PMC8395458/ /pubmed/34449579 http://dx.doi.org/10.3390/curroncol28050285 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aquilani, Roberto
Brugnatelli, Silvia
Maestri, Roberto
Boschi, Federica
Filippi, Beatrice
Perrone, Lorenzo
Barbieri, Annalisa
Buonocore, Daniela
Dossena, Maurizia
Verri, Manuela
Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State
title Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State
title_full Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State
title_fullStr Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State
title_full_unstemmed Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State
title_short Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State
title_sort peripheral blood lymphocyte percentage may predict chemotolerance and survival in patients with advanced pancreatic cancer. association between adaptive immunity and nutritional state
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395458/
https://www.ncbi.nlm.nih.gov/pubmed/34449579
http://dx.doi.org/10.3390/curroncol28050285
work_keys_str_mv AT aquilaniroberto peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT brugnatellisilvia peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT maestriroberto peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT boschifederica peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT filippibeatrice peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT perronelorenzo peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT barbieriannalisa peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT buonocoredaniela peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT dossenamaurizia peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate
AT verrimanuela peripheralbloodlymphocytepercentagemaypredictchemotoleranceandsurvivalinpatientswithadvancedpancreaticcancerassociationbetweenadaptiveimmunityandnutritionalstate